Large meals sit like rocks, causing nausea, bloating, and reflux
Trial results are expected mid-to-late 2026
Once-daily liraglutide versus lixisenatide as add-on to metformin in type 2 diabetes: A 26-week randomized controlled clinical trial
As Drucker points out, 'The strange thing is that you can't find many GLP-1 receptors in all these other organs where GLP-1 seems to work' (Lunenfeld-Tanenbaum Research Institute)
[2] Not to mention the potential unwanted side effects like nausea, constipation, bloating, and a concerningly low appetite make it hard to stick it out long-term
Safe GLP-1 therapy generally requires: Baseline metabolic laboratory testing Medication review Screening for thyroid and pancreatic history Ongoing clinical follow-up Lowering the dose does not eliminate contraindications